Jean-Claude Carine Lamercie 4
4 · ARROW ELECTRONICS, INC. · Filed Feb 24, 2026
Research Summary
AI-generated summary of this filing
Arrow Electronics (ARW) SVP Jean-Claude Lamercie Exercises Options, Sells Shares
What Happened
Jean-Claude Carine Lamercie, Senior Vice President, CLCO and Secretary of Arrow Electronics (ARW), exercised stock options and immediately sold the resulting shares on 2026-02-23. She exercised 2,187 options with a $73.86 exercise price (cost $161,532) and 1,891 options with an $81.95 exercise price (cost $154,967), for a total exercise cost of $316,499. The exercised shares (4,078 total) were sold in the open market the same day at $160.00 per share, producing gross proceeds of $652,480. The filing also records the conversion/disposition of the derivative instruments associated with those options.
Key Details
- Transaction date: 2026-02-23 (filed 2026-02-24; timely filing)
- Option exercises: 2,187 shares @ $73.86 (cost $161,532); 1,891 shares @ $81.95 (cost $154,967)
- Open-market sales: 2,187 shares @ $160.00 (proceeds $349,920); 1,891 shares @ $160.00 (proceeds $302,560)
- Total shares exercised/sold: 4,078; total proceeds: $652,480; total exercise cost: $316,499; gross cash difference: $335,981 (proceeds minus exercise cost)
- Footnotes: Options were granted under the company's 2004 Omnibus Incentive Plan — 2,187 options granted 2/21/2017 (fully vested) and 1,891 options granted 2/20/2018 (fully vested)
- Shares owned after transaction: Not disclosed in the provided excerpt
- Transaction codes: M = option exercise/conversion, S = open-market sale
Context
- This was an exercise of previously granted, fully vested options followed by same-day sales of the resulting shares (a cashless or simultaneous exercise-and-sell pattern). The filing shows both the acquisition from exercising the option and the subsequent sale/conversion of the derivative instrument. The filing does not state a reason for the sales; Form 4s report transactions but do not explain motivation.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-23$73.86/sh+2,187$161,532→ 17,813 total - Sale
Common Stock
2026-02-23$160.00/sh−2,187$349,920→ 15,626 total - Exercise/Conversion
Common Stock
2026-02-23$81.95/sh+1,891$154,967→ 17,517 total - Sale
Common Stock
2026-02-23$160.00/sh−1,891$302,560→ 15,626 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F1]2026-02-23−2,187→ 0 totalExercise: $73.86From: 2018-02-21Exp: 2027-02-19→ Common Stock (2,187 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-02-23−1,891→ 0 totalExercise: $81.95From: 2019-02-20Exp: 2028-02-18→ Common Stock (1,891 underlying)
Footnotes (2)
- [F1]The company granted these options on February 21, 2017 under the company's 2004 Omnibus Incentive Plan, as amended. The shares subject to the option were fully vested and exercisable.
- [F2]The company granted these options on February 20, 2018 under the company's 2004 Omnibus Incentive Plan, as amended. The shares subject to the option were fully vested and exercisable.